Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04312958 · ClinicalTrials.gov registry record
Quantra QStat in Trauma and Liver Transplant
A clinical trial of Trauma and Hemorrhage, sponsored by HemoSonics.
- Completed
- Registry status
- 397
- Enrollment target
- 10
- Study locations
NCT04312958: Completed study of Trauma and Hemorrhage, sponsored by HemoSonics.
NCT04312958 is a study of Trauma and Hemorrhage that has completed, run by HemoSonics. The registered enrollment target is 397 participants, above the 300-participant average among 56 other Trauma trials with a reported enrollment target (32% higher). The trial reports 10 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04312958, a study of Trauma and Hemorrhage, has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 397 participants
- Enrollment target
- 10
- Study locations
Study Summary
This is a multi-center prospective, observational study of the Quantra System with the QStat Cartridge in trauma patients and patients undergoing liver transplant.
Primary Outcome
Coagulation function assessed by Quantra and ROTEM Delta
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Quantra System
Study Locations (10)
Texas
- University of Texas Southwestern Medical Center - Dallas
- Texas Tech University Health Sciences Center - El Paso
California
- Zuckerberg San Francisco General Hospital and Trauma Center - San Francisco
Colorado
- University of Colorado - Denver
Florida
- University of Florida Health Shands Hospital - Gainesville
Michigan
- University of Michigan Medical Center - Ann Arbor
Ohio
- Ohio State University - Columbus
Oklahoma
- University of Oklahoma Medical Center - Oklahoma City
South Carolina
- Spartanburg Regional Medical Center - Spartanburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 397 participants |
| Start Date | 2020-07-20 |
| Est. Completion | 2023-04-13 |
What the finished NCT04312958 record still lists
NCT04312958 is an observational study that tracks outcomes without assigning an intervention. The registered 397 participants enrollment target is mid-sized for trials with a published cap, above the 300-participant average among 56 other Trauma trials with a reported enrollment target (32% higher).
The record links to 3 conditions, with Trauma appearing as the primary indexed condition, and to 1 intervention - of which Quantra System is the first listed.
NCT04312958 lists 10 locations in 9 states (Texas, California, Colorado).
Frequently Asked Questions
What is clinical trial NCT04312958 about?
NCT04312958 is a clinical study titled "Quantra QStat in Trauma and Liver Transplant". This is a multi-center prospective, observational study of the Quantra System with the QStat Cartridge in trauma patients and patients undergoing liver transplant.
What is the current status of trial NCT04312958?
This trial is currently completed. The enrollment target is 397 participants. The study started on 2020-07-20. Estimated completion is 2023-04-13.
What conditions does trial NCT04312958 study?
This clinical trial studies the following conditions: Trauma, Hemorrhage, Liver Transplant.
What interventions are being tested in trial NCT04312958?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04312958?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04312958 being conducted?
This trial has 10 study locations across California, Colorado, Florida, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04312958's enrollment target sits among peer trials
397 12th of 56 higher than 45 of 56 other Trauma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trauma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
Testing FIRST in Youth Outpatient Psychotherapy
RECRUITING · NA
-
PRESERVE & CONNECT: Impact Study of the BPC
RECRUITING · NA
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PMCF Study to Evaluate the VERTICALE® Cervical System in Spine Surgery According to Its Intended Use.
RECRUITING
-
Evaluation of the Parenting in the Moment Online Program for Forcibly Displaced Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00601939 · 397 participants · NA
Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships
- NCT04115254 · 397 participants · NA
Stereotactic Magnetic Resonance Guided Radiation Therapy
- NCT05365581 · 398 participants · Phase 1
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- NCT05633615 · 396 participants · Phase 2
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI